Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million

Quest Diagnostics CEO J. E. Davis sold 10,000 shares worth $2.4 million on September 1, 2026, under a pre-planned Rule 10b5-1 trading arrangement. The sale represents 8% of his direct holdings, leaving him with $28.9 million in company stock. Analysts view this as a routine portfolio adjustment rather than a sign of concern about the company's fundamentals.